annual EBITDA:
$10.56B-$3.08B(-22.59%)Summary
- As of today (April 13, 2025), SNY annual EBITDA is $10.56 billion, with the most recent change of -$3.08 billion (-22.59%) on December 1, 2024.
- During the last 3 years, SNY annual EBITDA has fallen by -$3.09 billion (-22.63%).
- SNY annual EBITDA is now -48.28% below its all-time high of $20.42 billion, reached on December 31, 2020.
Performance
SNY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$1.86B-$2.81B(-60.15%)Summary
- As of today (April 13, 2025), SNY quarterly EBITDA is $1.86 billion, with the most recent change of -$2.81 billion (-60.15%) on December 1, 2024.
- Over the past year, SNY quarterly EBITDA has stayed the same.
- SNY quarterly EBITDA is now -82.50% below its all-time high of $10.64 billion, reached on March 31, 2008.
Performance
SNY quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$11.06B+$1.40B(+14.53%)Summary
- As of today (April 13, 2025), SNY TTM EBITDA is $11.06 billion, with the most recent change of +$1.40 billion (+14.53%) on December 1, 2024.
- Over the past year, SNY TTM EBITDA has stayed the same.
- SNY TTM EBITDA is now -41.98% below its all-time high of $19.06 billion, reached on December 31, 2008.
Performance
SNY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SNY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.6% | 0.0% | 0.0% |
| 3 y3 years | -22.6% | -41.9% | -6.3% |
| 5 y5 years | -11.5% | -41.9% | -6.3% |
SNY EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.0% | at low | -61.3% | +306.6% | -26.8% | +19.6% |
| 5 y | 5-year | -48.3% | at low | -80.2% | +306.6% | -28.9% | +108.7% |
| alltime | all time | -48.3% | +721.8% | -82.5% | +108.6% | -42.0% | +418.2% |
Sanofi EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $10.56B(-22.6%) | $1.86B(-60.2%) | $11.06B(+14.5%) |
| Sep 2024 | - | $4.67B(+114.1%) | $9.66B(+4.4%) |
| Jun 2024 | - | $2.18B(-7.1%) | $9.25B(-5.3%) |
| Mar 2024 | - | $2.35B(+413.1%) | $9.77B(-9.2%) |
| Dec 2023 | $13.65B(-9.5%) | $457.69M(-89.3%) | $10.76B(-28.8%) |
| Sep 2023 | - | $4.26B(+57.9%) | $15.11B(+5.4%) |
| Jun 2023 | - | $2.70B(-19.2%) | $14.34B(+4.8%) |
| Mar 2023 | - | $3.34B(-30.4%) | $13.68B(+1.0%) |
| Dec 2022 | $15.08B(+10.5%) | $4.81B(+37.8%) | $13.54B(+23.5%) |
| Sep 2022 | - | $3.49B(+70.8%) | $10.96B(-4.7%) |
| Jun 2022 | - | $2.04B(-36.3%) | $11.51B(-2.5%) |
| Mar 2022 | - | $3.20B(+43.8%) | $11.80B(+2.1%) |
| Dec 2021 | $13.65B(-33.2%) | $2.23B(-44.7%) | $11.56B(+23.9%) |
| Sep 2021 | - | $4.03B(+72.6%) | $9.33B(+76.0%) |
| Jun 2021 | - | $2.34B(-21.2%) | $5.30B(-57.1%) |
| Mar 2021 | - | $2.97B(-68.4%) | $12.35B(-20.6%) |
| Dec 2020 | $20.42B(+71.1%) | - | - |
| Jun 2020 | - | $9.38B(+236.7%) | $15.55B(+138.9%) |
| Mar 2020 | - | $2.79B(+599.3%) | $6.51B(+8.2%) |
| Dec 2019 | $11.94B(+10.1%) | $398.64M(-86.6%) | $6.01B(-3.4%) |
| Sep 2019 | - | $2.98B(+772.9%) | $6.23B(-11.7%) |
| Jun 2019 | - | $341.51M(-85.1%) | $7.05B(-17.1%) |
| Mar 2019 | - | $2.29B(+274.1%) | $8.51B(+1.6%) |
| Dec 2018 | $10.84B(-0.7%) | $612.69M(-83.9%) | $8.37B(-8.9%) |
| Sep 2018 | - | $3.81B(+112.3%) | $9.19B(+11.4%) |
| Jun 2018 | - | $1.79B(-16.9%) | $8.25B(-3.6%) |
| Mar 2018 | - | $2.16B(+50.4%) | $8.56B(-2.7%) |
| Dec 2017 | $10.91B(-0.4%) | $1.43B(-50.0%) | $8.80B(-7.2%) |
| Sep 2017 | - | $2.87B(+36.5%) | $9.48B(-2.8%) |
| Jun 2017 | - | $2.10B(-12.4%) | $9.75B(-0.6%) |
| Mar 2017 | - | $2.40B(+13.3%) | $9.81B(+6.8%) |
| Dec 2016 | $10.96B(-2.0%) | $2.12B(-32.5%) | $9.19B(+17.6%) |
| Sep 2016 | - | $3.14B(+45.6%) | $7.81B(+3.7%) |
| Jun 2016 | - | $2.15B(+21.3%) | $7.54B(-6.8%) |
| Mar 2016 | - | $1.78B(+139.1%) | $8.09B(-3.5%) |
| Dec 2015 | $11.18B(-11.8%) | $742.91M(-74.0%) | $8.38B(-15.7%) |
| Sep 2015 | - | $2.86B(+5.8%) | $9.94B(-2.6%) |
| Jun 2015 | - | $2.71B(+30.7%) | $10.21B(+0.7%) |
| Mar 2015 | - | $2.07B(-10.1%) | $10.14B(-8.6%) |
| Dec 2014 | $12.68B(-6.3%) | $2.30B(-26.3%) | $11.10B(+1.7%) |
| Sep 2014 | - | $3.13B(+18.7%) | $10.92B(+0.3%) |
| Jun 2014 | - | $2.63B(-13.0%) | $10.89B(+7.0%) |
| Mar 2014 | - | $3.03B(+42.6%) | $10.17B(+0.5%) |
| Dec 2013 | $13.53B | $2.12B(-31.5%) | $10.12B(+5.7%) |
| Sep 2013 | - | $3.10B(+61.5%) | $9.57B(-6.8%) |
| Jun 2013 | - | $1.92B(-35.5%) | $10.27B(-11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $2.97B(+88.4%) | $11.53B(-8.5%) |
| Dec 2012 | $14.69B(-8.8%) | $1.58B(-58.4%) | $12.60B(-7.5%) |
| Sep 2012 | - | $3.80B(+19.3%) | $13.63B(-4.8%) |
| Jun 2012 | - | $3.18B(-21.3%) | $14.31B(+12.2%) |
| Mar 2012 | - | $4.04B(+55.1%) | $12.75B(+9.9%) |
| Dec 2011 | $16.11B(+3.3%) | $2.61B(-41.8%) | $11.61B(+2.6%) |
| Sep 2011 | - | $4.48B(+175.4%) | $11.32B(+11.3%) |
| Jun 2011 | - | $1.63B(-43.8%) | $10.17B(-20.1%) |
| Mar 2011 | - | $2.90B(+25.1%) | $12.73B(-8.0%) |
| Dec 2010 | $15.60B(-1.9%) | $2.31B(-30.6%) | $13.83B(-9.3%) |
| Sep 2010 | - | $3.33B(-20.3%) | $15.26B(-2.8%) |
| Jun 2010 | - | $4.18B(+4.4%) | $15.69B(+8.3%) |
| Mar 2010 | - | $4.00B(+7.1%) | $14.49B(+1.1%) |
| Dec 2009 | $15.90B(+3.3%) | $3.74B(-0.7%) | $14.33B(+27.7%) |
| Sep 2009 | - | $3.77B(+26.5%) | $11.22B(-1.9%) |
| Jun 2009 | - | $2.98B(-22.5%) | $11.43B(-6.8%) |
| Mar 2009 | - | $3.84B(+507.9%) | $12.27B(-35.6%) |
| Dec 2008 | $15.38B(+4.2%) | $632.11M(-84.1%) | $19.06B(-679.5%) |
| Sep 2008 | - | $3.98B(+4.3%) | -$3.29B(-242.1%) |
| Jun 2008 | - | $3.82B(-64.1%) | $2.32B(+16.9%) |
| Mar 2008 | - | $10.64B(-149.0%) | $1.98B(+234.8%) |
| Dec 2007 | $14.76B(-3.1%) | -$21.72B(-326.6%) | $591.41M(-61.4%) |
| Sep 2007 | - | $9.59B(+175.5%) | $1.53B(+16.1%) |
| Jun 2007 | - | $3.48B(-62.4%) | $1.32B(+179.2%) |
| Mar 2007 | - | $9.25B(-144.5%) | $472.75M(-113.6%) |
| Dec 2006 | $15.23B(+4.9%) | -$20.78B(-321.7%) | -$3.48B(-125.0%) |
| Sep 2006 | - | $9.37B(+256.0%) | $13.92B(+37.8%) |
| Jun 2006 | - | $2.63B(-50.3%) | $10.10B(-3.7%) |
| Mar 2006 | - | $5.30B(-256.6%) | $10.49B(+0.0%) |
| Dec 2005 | $14.52B(+100.6%) | -$3.38B(-160.9%) | $10.49B(+77.6%) |
| Sep 2005 | - | $5.55B(+83.5%) | $5.91B(-14.1%) |
| Jun 2005 | - | $3.02B(-42.9%) | $6.88B(+42.8%) |
| Mar 2005 | - | $5.30B(-166.5%) | $4.82B(+109.2%) |
| Dec 2004 | $7.24B(+84.8%) | -$7.96B(-222.1%) | $2.30B(-64.4%) |
| Sep 2004 | - | $6.52B(+578.3%) | $6.46B(+143.0%) |
| Jun 2004 | - | $961.72M(-65.4%) | $2.66B(+5.2%) |
| Mar 2004 | - | $2.78B(-173.1%) | $2.53B(+37.9%) |
| Dec 2003 | $3.92B(+38.2%) | -$3.81B(-239.9%) | $1.83B(-31.7%) |
| Sep 2003 | - | $2.72B(+228.0%) | $2.68B(+48.9%) |
| Jun 2003 | - | $829.44M(-60.3%) | $1.80B(+15.1%) |
| Mar 2003 | - | $2.09B(-170.6%) | $1.56B(-399.1%) |
| Dec 2002 | $2.83B(+31.4%) | -$2.96B(-260.7%) | -$523.07M(-121.5%) |
| Sep 2002 | - | $1.84B(+210.2%) | $2.43B(+310.2%) |
| Jun 2002 | - | $593.09M | $593.09M |
| Dec 2001 | $2.16B(+28.4%) | - | - |
| Dec 2000 | $1.68B(+30.7%) | - | - |
| Dec 1999 | $1.29B | - | - |
FAQ
- What is Sanofi annual EBITDA?
- What is the all time high annual EBITDA for Sanofi?
- What is Sanofi annual EBITDA year-on-year change?
- What is Sanofi quarterly EBITDA?
- What is the all time high quarterly EBITDA for Sanofi?
- What is Sanofi quarterly EBITDA year-on-year change?
- What is Sanofi TTM EBITDA?
- What is the all time high TTM EBITDA for Sanofi?
- What is Sanofi TTM EBITDA year-on-year change?
What is Sanofi annual EBITDA?
The current annual EBITDA of SNY is $10.56B
What is the all time high annual EBITDA for Sanofi?
Sanofi all-time high annual EBITDA is $20.42B
What is Sanofi annual EBITDA year-on-year change?
Over the past year, SNY annual EBITDA has changed by -$3.08B (-22.59%)
What is Sanofi quarterly EBITDA?
The current quarterly EBITDA of SNY is $1.86B
What is the all time high quarterly EBITDA for Sanofi?
Sanofi all-time high quarterly EBITDA is $10.64B
What is Sanofi quarterly EBITDA year-on-year change?
Over the past year, SNY quarterly EBITDA has changed by $0.00 (0.00%)
What is Sanofi TTM EBITDA?
The current TTM EBITDA of SNY is $11.06B
What is the all time high TTM EBITDA for Sanofi?
Sanofi all-time high TTM EBITDA is $19.06B
What is Sanofi TTM EBITDA year-on-year change?
Over the past year, SNY TTM EBITDA has changed by $0.00 (0.00%)